INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.68 Million USD | 225.93% |
| 2022 | 2.66 Million USD | 25.46% |
| 2021 | 2.12 Million USD | 174.0% |
| 2020 | 775.02 Thousand USD | 69.42% |
| 2019 | 457.46 Thousand USD | 15.64% |
| 2018 | 395.59 Thousand USD | 15.46% |
| 2017 | 342.61 Thousand USD | -2.84% |
| 2016 | 352.61 Thousand USD | 59.63% |
| 2015 | 220.88 Thousand USD | -59.16% |
| 2014 | 540.88 Thousand USD | 13.9% |
| 2013 | 474.88 Thousand USD | 0.0% |
| 2012 | 474.88 Thousand USD | -2.55% |
| 2011 | 487.29 Thousand USD | 5.34% |
| 2010 | 462.58 Thousand USD | 121.79% |
| 2009 | 208.56 Thousand USD | 42.4% |
| 2008 | 146.46 Thousand USD | 73131.0% |
| 2007 | 200.00 USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 5.37 Million USD | -15.73% |
| 2024 Q1 | 6.37 Million USD | -26.53% |
| 2023 FY | 8.68 Million USD | 225.93% |
| 2023 Q3 | 8.8 Million USD | 71.51% |
| 2023 Q4 | 8.68 Million USD | -1.39% |
| 2023 Q2 | 5.13 Million USD | 74.27% |
| 2023 Q1 | 2.94 Million USD | 10.58% |
| 2022 Q3 | 1.95 Million USD | -2.78% |
| 2022 Q4 | 2.66 Million USD | 36.06% |
| 2022 FY | 2.66 Million USD | 25.46% |
| 2022 Q1 | 2.06 Million USD | -2.56% |
| 2022 Q2 | 2.01 Million USD | -2.66% |
| 2021 Q1 | 418.92 Thousand USD | -45.95% |
| 2021 Q2 | 1.7 Million USD | 306.32% |
| 2021 FY | 2.12 Million USD | 174.0% |
| 2021 Q4 | 2.12 Million USD | 19.59% |
| 2021 Q3 | 1.77 Million USD | 4.32% |
| 2020 Q1 | 502.54 Thousand USD | 9.85% |
| 2020 FY | 775.02 Thousand USD | 69.42% |
| 2020 Q3 | 851.93 Thousand USD | -21.86% |
| 2020 Q2 | 1.09 Million USD | 116.95% |
| 2020 Q4 | 775.02 Thousand USD | -9.03% |
| 2019 Q2 | 401.1 Thousand USD | 64.14% |
| 2019 Q3 | 411.8 Thousand USD | 2.67% |
| 2019 FY | 457.46 Thousand USD | 15.64% |
| 2019 Q4 | 457.46 Thousand USD | 11.09% |
| 2019 Q1 | 244.36 Thousand USD | -38.23% |
| 2018 Q1 | 342.61 Thousand USD | 0.0% |
| 2018 FY | 395.59 Thousand USD | 15.46% |
| 2018 Q4 | 395.59 Thousand USD | -0.02% |
| 2018 Q3 | 395.68 Thousand USD | 6.64% |
| 2018 Q2 | 371.05 Thousand USD | 8.3% |
| 2017 Q1 | 342.61 Thousand USD | -2.84% |
| 2017 Q3 | 342.61 Thousand USD | 0.0% |
| 2017 Q2 | 342.61 Thousand USD | 0.0% |
| 2017 Q4 | 342.61 Thousand USD | 0.0% |
| 2017 FY | 342.61 Thousand USD | -2.84% |
| 2016 FY | 352.61 Thousand USD | 59.63% |
| 2016 Q3 | 352.61 Thousand USD | 59.63% |
| 2016 Q1 | 220.88 Thousand USD | 0.0% |
| 2016 Q2 | 220.88 Thousand USD | 0.0% |
| 2016 Q4 | 352.61 Thousand USD | 0.0% |
| 2015 FY | 220.88 Thousand USD | -59.16% |
| 2015 Q4 | 220.88 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | 540.88 Thousand USD | 13.9% |
| 2013 FY | 474.88 Thousand USD | 0.0% |
| 2012 FY | 474.88 Thousand USD | -2.55% |
| 2011 Q3 | 130.48 Thousand USD | -74.14% |
| 2011 Q1 | 456.52 Thousand USD | -1.31% |
| 2011 Q4 | 487.29 Thousand USD | 273.46% |
| 2011 Q2 | 504.59 Thousand USD | 10.53% |
| 2011 FY | 487.29 Thousand USD | 5.34% |
| 2010 Q4 | 462.58 Thousand USD | -4.28% |
| 2010 Q3 | 483.27 Thousand USD | 30.1% |
| 2010 Q2 | 371.46 Thousand USD | 54.74% |
| 2010 Q1 | 240.06 Thousand USD | 15.1% |
| 2010 FY | 462.58 Thousand USD | 121.79% |
| 2009 FY | 208.56 Thousand USD | 42.4% |
| 2009 Q4 | 208.56 Thousand USD | -0.89% |
| 2009 Q1 | 221.46 Thousand USD | 51.21% |
| 2009 Q3 | 210.43 Thousand USD | -10.25% |
| 2009 Q2 | 234.46 Thousand USD | 5.87% |
| 2008 Q2 | 8162.00 USD | 6.86% |
| 2008 Q1 | 7638.00 USD | 3719.0% |
| 2008 Q4 | 146.46 Thousand USD | 0.0% |
| 2008 Q3 | - USD | -100.0% |
| 2008 FY | 146.46 Thousand USD | 73131.0% |
| 2007 FY | 200.00 USD | 0.0% |
| 2007 Q4 | 200.00 USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 98.397% |
| Nemaura Medical Inc. | 20.03 Million USD | 56.648% |
| NeuroPace, Inc. | 72.39 Million USD | 88.005% |
| LENSAR, Inc. | 2.3 Million USD | -276.075% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -18.208% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -444.424% |
| Apyx Medical Corporation | 38.5 Million USD | 77.446% |
| Cutera, Inc. | 431.91 Million USD | 97.99% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 44.454% |
| BioSig Technologies, Inc. | 452 Thousand USD | -1821.142% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 77.859% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.484% |
| Axonics, Inc. | 27.61 Million USD | 68.557% |
| IRIDEX Corporation | 2.74 Million USD | -216.226% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 89.036% |
| TELA Bio, Inc. | 42.78 Million USD | 79.702% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -2253.269% |
| RxSight, Inc. | 3.01 Million USD | -188.299% |
| Align Technology, Inc. | 96.96 Million USD | 91.045% |
| electroCore, Inc. | 626 Thousand USD | -1287.15% |
| Telesis Bio, Inc. | 34.38 Million USD | 74.742% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 15.457% |
| Quipt Home Medical Corp. | 98.94 Million USD | 91.224% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 70.095% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -269.828% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 43.077% |
| Dynatronics Corporation | 6.68 Million USD | -29.839% |
| Modular Medical, Inc. | 1.19 Million USD | -629.711% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -3214.336% |
| Talis Biomedical Corporation | 19.66 Million USD | 55.849% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -536.14% |
| InMode Ltd. | 9.01 Million USD | 3.698% |
| Envoy Medical, Inc. | 404 Thousand USD | -2049.396% |
| Bruker Corporation | 1.37 Billion USD | 99.371% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -15134.318% |
| DexCom, Inc. | 2.59 Billion USD | 99.665% |
| Nexalin Technology, Inc. | 4463.00 USD | -194467.802% |
| PAVmed Inc | 48.72 Million USD | 82.178% |
| Viveve Medical, Inc. | 5.34 Million USD | -62.34% |
| Cerus Corporation | 95.99 Million USD | 90.955% |
| Movano Inc. | 252 Thousand USD | -3345.858% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 73.824% |
| Nexalin Technology, Inc. | 4463.00 USD | -194467.802% |
| IceCure Medical Ltd | 599 Thousand USD | -1349.676% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 97.911% |
| enVVeno Medical Corporation | 1.4 Million USD | -519.37% |
| 908 Devices Inc. | 5.94 Million USD | -46.065% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 37.712% |
| Orthofix Medical Inc. | 134.19 Million USD | 93.529% |
| Surmodics, Inc. | 29.4 Million USD | 70.469% |
| Nuwellis, Inc. | 981 Thousand USD | -785.174% |
| Outset Medical, Inc. | 136.18 Million USD | 93.624% |
| Venus Concept Inc. | 79.69 Million USD | 89.104% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 93.311% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 87.648% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -3.425% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -823.473% |
| Inogen, Inc. | 21.92 Million USD | 60.391% |
| IRadimed Corporation | 2.04 Million USD | -325.031% |
| MaxCyte, Inc. | 18.74 Million USD | 53.67% |
| Pulmonx Corporation | 41.42 Million USD | 79.037% |
| PAVmed Inc. | 48.72 Million USD | 82.178% |
| iCAD, Inc. | 461 Thousand USD | -1783.636% |
| OrthoPediatrics Corp. | 23.76 Million USD | 63.453% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -334.939% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -1664.984% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -4609.089% |
| SI-BONE, Inc. | 38.99 Million USD | 77.73% |
| Semler Scientific, Inc. | 70 Thousand USD | -12305.087% |
| Beyond Air, Inc. | 17.83 Million USD | 51.317% |
| FONAR Corporation | 41.67 Million USD | 79.164% |
| AxoGen, Inc. | 69.29 Million USD | 87.468% |
| Biotricity, Inc. | 23.87 Million USD | 63.635% |
| Cytosorbents Corporation | 18.31 Million USD | 52.583% |
| ZimVie Inc. | 521.92 Million USD | 98.336% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 82.762% |
| Inari Medical, Inc. | 32.04 Million USD | 72.904% |
| UFP Technologies, Inc. | 46.03 Million USD | 81.138% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -334.939% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -182.754% |
| Sight Sciences, Inc. | 35.41 Million USD | 75.48% |
| Insulet Corporation | 1.44 Billion USD | 99.401% |
| Profound Medical Corp. | 7.9 Million USD | -9.913% |
| Bioventus Inc. | 409.47 Million USD | 97.879% |
| InspireMD, Inc. | 1.59 Million USD | -444.424% |
| BrainsWay Ltd. | 471 Thousand USD | -1743.644% |
| BIOLASE, Inc. | 17.91 Million USD | 51.516% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -737.908% |
| Tenon Medical, Inc. | 1.17 Million USD | -640.287% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -766.623% |
| CVRx, Inc. | 30.61 Million USD | 71.634% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.622% |
| Sintx Technologies, Inc. | 4.24 Million USD | -104.56% |
| Acutus Medical, Inc. | 38.47 Million USD | 77.433% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -335.266% |
| NanoVibronix, Inc. | 5000.00 USD | -173571.22% |
| Quanterix Corporation | 41.46 Million USD | 79.058% |
| LivaNova PLC | 640.4 Million USD | 98.644% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -190.365% |
| Varex Imaging Corporation | 469.5 Million USD | 98.15% |
| Vivani Medical, Inc. | 20.69 Million USD | 58.042% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -269.828% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -1009.012% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.07% |
| TransMedics Group, Inc. | 515.94 Million USD | 98.317% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -356.309% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -3504.992% |
| Spectral AI, Inc. | 1.28 Million USD | -573.666% |
| Hyperfine, Inc. | 185 Thousand USD | -4593.817% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 95.483% |
| Biomerica, Inc. | 785 Thousand USD | -1006.186% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1831.9% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -2246.243% |
| Silk Road Medical, Inc | 84.63 Million USD | 89.74% |